RxDoctor Payments Data

Elisabeth Casario, DO

Family Medicine · Murrysville, PANPI 1427112267

Payments from drug & device makers

$11,411in general payments, 2019–2025

Across 654 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • GSK$1K
  • Pfizer$795
  • Amgen$747
  • Lilly USA, LLC$715
  • plus $4K from 53 others

What the payments were for

  • Food & beverage$11,22798%
  • Education$1842%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie128$1,895
Novo Nordisk100$1,745
GSK59$1,114
Pfizer45$795
Amgen(2 entities)44$747
Lilly USA, LLC42$715
AstraZeneca35$633
Astellas Pharma US Inc18$473
Merck22$368
Johnson & Johnson14$235
Amarin Pharma, Inc.12$205
E.r. Squibb & Sons, L.L.C.11$195
Amneal Pharmaceuticals LLC7$149
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$143
Daiichi Sankyo Inc.9$140
CSL Behring5$134
Exact Sciences4$116
Biohaven Pharmaceutical Holding Company Ltd.6$104
Currax Pharmaceuticals LLC7$102
Takeda Pharmaceuticals U.S.A., Inc.6$95
Kaleo, Inc.6$91
Paratek Pharmaceuticals, Inc.4$81
Genentech USA, Inc.4$65
Eisai Inc.4$64
Teva Pharmaceuticals USA, Inc.4$64
Boehringer Ingelheim4$61
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$55
Upsher-smith Laboratories LLC3$47
Abbott2$45
Seqirus USA Inc2$41
ARS Pharmaceuticals Operations, Inc.2$38
Inari Medical, Inc.1$38
Sanofi-aventis U.S. LLC2$37
Biohaven Pharmaceuticals, Inc.2$37
Dexcom, Inc.2$36
Xeris Pharmaceuticals, Inc.2$35
Tactile Systems Technology Inc2$35
Bayer2$33
Neos Therapeutics, LP2$30
Edwards Lifesciences1$28
Cranial Technologies, Inc1$25
Esperion Therapeutics, Inc.1$25
Ionis Pharmaceuticals, Inc.1$24
Idorsia Pharmaceuticals US Inc1$24
Ardelyx, Inc.1$21
Pulmonx Corporation1$21
Electromed, Inc.1$21
Organon1$20
Nabriva Therapeutics, PLC1$19
Phadia US Inc.1$18
Pacira Therapeutics, Inc.1$17
Hologic Sales And Service, LLC1$16
Ironshore Pharmaceuticals Inc.1$16
Melinta Therapeutics, LLC1$15
Kowa Pharmaceuticals America, Inc.1$14
Shire North American Group Inc1$14
Supernus Pharmaceuticals, Inc.1$13
Biogen1$13
Nalpropion Pharmaceuticals LLC1$12

How this compares

$11,411 in reported general payments places this provider in the 90th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$38,883
Medicare patients
146
Services billed
577

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide47$61,476
EliquisApixaban53$56,269
JardianceEmpagliflozin15$25,960
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$22,767
MounjaroTirzepatide17$22,362
XareltoRivaroxaban14$17,425
TrulicityDulaglutide12$10,667
SynthroidLevothyroxine Sodium68$4,984
Levothyroxine Sodium248$4,111
Atorvastatin Calcium293$2,525
Bupropion XlBupropion Hcl25$1,679
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide29$1,477
Metoprolol Succinate96$1,359
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$1,322
Lisinopril235$1,289

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,745$61,47647 claims
PfizerEliquis$795$56,26953 claims
Lilly USA, LLCMounjaro, Trulicity$715$33,02929 claims
Boehringer IngelheimJardiance$61$25,96015 claims
GSKTrelegy Ellipta$1,114$22,76718 claims
Johnson & JohnsonXarelto$235$17,42514 claims
AbbVieSynthroid$1,895$4,98468 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$149$4,111248 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Murrysville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →